N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide

C137H155F9N26O15 — CID 155448917

About N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 155448917) has the molecular formula C137H155F9N26O15 and a molecular weight of 2576.90 g/mol. Its IUPAC name is N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

• Compound Name: N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide
• PubChem CID: 155448917
• Molecular Formula: C137H155F9N26O15
• Molecular Weight: 2576.90 g/mol
• Exact Mass: 2575.20
• IUPAC Name: N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide
• SMILES: Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(CCN3CC4(CCN(CC5CCC(n6cc7cc(NC(=O)c8cc(OC(C)(C)c9cc%10nn(C%11CCC(CN%12CCC%13(CC%12)CC(Cc%12cccc%14c%12n(C)c(=O)n%14C%12CCC(=O)NC%12=O)C%13)CC%11)cc%10cc9NC(=O)c9nc(C(F)(F)F)ccc9CC(C)(O)c9cc%10nn(C%11CCC(CN%12CCC%13(CC%12)CN(Cc%12cccc%14c%12n(C)c(=O)n%14C%12CCC(=O)NC%12=O)C%13)CC%11)cc%10cc9NC(=O)c9cccc(C(F)(F)F)n9)cc(C(F)(F)F)n8)c(C(C)(C)O)cc7n6)CC5)CC4)C3)c21
• InChI: InChI=1S/C137H155F9N26O15/c1-129(2,185)93-61-97-86(71-167(156-97)89-28-23-79(24-29-89)68-163-51-44-133(45-52-163)74-165(75-133)48-41-82-13-9-17-104-117(82)159(6)126(182)170(104)107-34-38-113(173)153-122(107)178)56-100(93)149-121(177)103-59-92(60-112(148-103)137(144,145)146)187-130(3,4)94-62-98-87(72-168(157-98)90-30-21-78(22-31-90)67-162-49-42-132(43-50-162)64-81(65-132)55-83-14-10-18-105-118(83)160(7)127(183)171(105)108-35-39-114(174)154-123(108)179)57-101(94)151-125(181)116-84(27-37-111(152-116)136(141,142)143)66-131(5,186)95-63-99-88(58-102(95)150-120(176)96-16-12-20-110(147-96)135(138,139)140)73-169(158-99)91-32-25-80(26-33-91)69-164-53-46-134(47-54-164)76-166(77-134)70-85-15-11-19-106-119(85)161(8)128(184)172(106)109-36-40-115(175)155-124(109)180/h9-20,27,37,56-63,71-73,78-81,89-91,107-109,185-186H,21-26,28-36,38-55,64-70,74-77H2,1-8H3,(H,149,177)(H,150,176)(H,151,181)(H,153,173,178)(H,154,174,179)(H,155,175,180)
• InChIKey: PHDGVENINCWUQY-UHFFFAOYSA-N
• XLogP: 18.79
• TPSA: 464.62 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 35
• Rotatable Bonds: 32
• Heavy Atoms: 187
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2576.90
LogP ≤ 5	18.79
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	35

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide?

The IUPAC name of N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 155448917) is N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide.

What is the SMILES notation for N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide?

The canonical SMILES for N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide is Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(CCN3CC4(CCN(CC5CCC(n6cc7cc(NC(=O)c8cc(OC(C)(C)c9cc%10nn(C%11CCC(CN%12CCC%13(CC%12)CC(Cc%12cccc%14c%12n(C)c(=O)n%14C%12CCC(=O)NC%12=O)C%13)CC%11)cc%10cc9NC(=O)c9nc(C(F)(F)F)ccc9CC(C)(O)c9cc%10nn(C%11CCC(CN%12CCC%13(CC%12)CN(Cc%12cccc%14c%12n(C)c(=O)n%14C%12CCC(=O)NC%12=O)C%13)CC%11)cc%10cc9NC(=O)c9cccc(C(F)(F)F)n9)cc(C(F)(F)F)n8)c(C(C)(C)O)cc7n6)CC5)CC4)C3)c21.

What is the InChIKey of N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide?

The InChIKey is PHDGVENINCWUQY-UHFFFAOYSA-N. The full InChI is InChI=1S/C137H155F9N26O15/c1-129(2,185)93-61-97-86(71-167(156-97)89-28-23-79(24-29-89)68-163-51-44-133(45-52-163)74-165(75-133)48-41-82-13-9-17-104-117(82)159(6)126(182)170(104)107-34-38-113(173)153-122(107)178)56-100(93)149-121(177)103-59-92(60-112(148-103)137(144,145)146)187-130(3,4)94-62-98-87(72-168(157-98)90-30-21-78(22-31-90)67-162-49-42-132(43-50-162)64-81(65-132)55-83-14-10-18-105-118(83)160(7)127(183)171(105)108-35-39-114(174)154-123(108)179)57-101(94)151-125(181)116-84(27-37-111(152-116)136(141,142)143)66-131(5,186)95-63-99-88(58-102(95)150-120(176)96-16-12-20-110(147-96)135(138,139)140)73-169(158-99)91-32-25-80(26-33-91)69-164-53-46-134(47-54-164)76-166(77-134)70-85-15-11-19-106-119(85)161(8)128(184)172(106)109-36-40-115(175)155-124(109)180/h9-20,27,37,56-63,71-73,78-81,89-91,107-109,185-186H,21-26,28-36,38-55,64-70,74-77H2,1-8H3,(H,149,177)(H,150,176)(H,151,181)(H,153,173,178)(H,154,174,179)(H,155,175,180).

What are the key properties of N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide?

N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 2576.90 g/mol, XLogP of 18.79, 32 rotatable bonds, 8 hydrogen bond donors, and 35 hydrogen bond acceptors.

Where does this data come from?

All data for N-[6-[2-[[2-[[2-[4-[[2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]carbamoyl]-6-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]indazol-5-yl]-3-[2-[2-[4-[[2-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 155448917), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).